Search

Your search keyword '"Cerhan, James R."' showing total 3,102 results

Search Constraints

Start Over You searched for: Author "Cerhan, James R." Remove constraint Author: "Cerhan, James R."
3,102 results on '"Cerhan, James R."'

Search Results

201. Primary Prevention of Cancer

204. Two high-risk susceptibility loci at 6p25.3 and 14q32.13 for Waldenström macroglobulinemia

207. History of autoimmune conditions and lymphoma prognosis

210. Revised MALT‐IPI: A new predictive model that identifies high‐risk patients with extranodal marginal zone lymphoma

211. Physical activity and the risk of non‐Hodgkin lymphoma subtypes: A pooled analysis

212. Patient Experience in Clinical Trials: Quality of Life, Financial Burden, and Perception of Care in Patients With Multiple Myeloma or Lymphoma Enrolled on Clinical Trials Compared With Standard Care

213. Cytokine gene polymorphisms and progression-free survival in classical Hodgkin lymphoma by EBV status: Results from two independent cohorts

216. The Mayo Clinic Biobank: A Building Block for Individualized Medicine

218. The significance of gradient expression of chromosome region maintenance protein 1 in large cell lymphoma

219. Household endotoxin levels and the risk of non-Hodgkin lymphoma

220. Smoking, variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2), and risk of non-Hodgkin lymphoma: a pooled analysis within the InterLymph consortium

221. Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypes

222. Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypes

223. Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypes

224. B-Cell NHL Subtype Risk Associated with Autoimmune Conditions and PRS

225. Cohort Profile: The Lymphoma Specialized Program of Research Excellence (SPORE) Molecular Epidemiology Resource (MER) Cohort Study

234. Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing

236. A genome-wide meta-analysis of nodular sclerosing Hodgkin lymphoma identifies risk loci at 6p21.32

237. Abstract 741: Evaluation of etiologic heterogeneity for risk of diffuse large B-cell lymphoma (DLBCL) subtype defined by cell-of-origin

238. Abstract 5256: Incidence of squamous cell carcinoma (SCC) in a large screening cohort of monoclonal B-cell lymphocytosis (MBL)

240. Long-Term Health-Related Quality of Life of Autologous Hematopoietic Cell Transplantation Patients and Nontransplant Patients With Aggressive Lymphoma: A Prospective Cohort Analysis

242. PET2 response associated with survival in newly diagnosed diffuse large B-cell lymphoma: results of two independent prospective cohorts

244. Revised MALT-IPI: A new predictive model that identifies high-risk patients with extranodal marginal zone lymphoma

247. Author Correction: Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes

Catalog

Books, media, physical & digital resources